Assyro AI

Orange Book product · Brand (NDA)

EPIDIOLEX

CANNABIDIOL

Brand (NDA)NDA 210365RX JAZZ PHARMS RES

At a glance

Sep 28, 2018

Approved

Brand (NDA)

Application

Not listed

TE code

57

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Sep 28, 2018

    7 yr 10 mo ago

  2. Today

  3. Exclusivity ends · M-270

    New use / labeling-change exclusivity (3 years)

    Oct 20, 2026

    in 4 mo

  4. Exclusivity ends · ODE-326

    Orphan-drug exclusivity (7 years)

    Jul 31, 2027

    in 1 yr 2 mo

  5. Exclusivity ends · ODE-332

    Orphan-drug exclusivity (7 years)

    Jul 31, 2027

    in 1 yr 2 mo

  6. Patent 10092525 expires

    Listed method-of-use patent (U-2427) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  7. Patent 10111840 expires

    Listed method-of-use patent (U-2443) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  8. Patent 10111840 expires

    Listed method-of-use patent (U-2442) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  9. Patent 10137095 expires

    Listed method-of-use patent (U-2454) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  10. Patent 10137095 expires

    Listed method-of-use patent (U-2455) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  11. Patent 10603288 expires

    Listed method-of-use patent (U-2780) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  12. Patent 10603288 expires

    Listed method-of-use patent (U-2781) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  13. Patent 10603288 expires

    Listed method-of-use patent (U-2782) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  14. Patent 10603288 expires

    Listed method-of-use patent (U-2783) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  15. Patent 10709671 expires

    Listed method-of-use patent (U-2862) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  16. Patent 10709673 expires

    Listed drug product patent expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  17. Patent 10709674 expires

    Listed method-of-use patent (U-2781) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  18. Patent 10709674 expires

    Listed method-of-use patent (U-2780) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  19. Patent 10849860 expires

    Listed method-of-use patent (U-2427) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  20. Patent 10849860 expires

    Listed method-of-use patent (U-2454) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  21. Patent 10966939 expires

    Listed drug product patent expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  22. Patent 10966939 expires

    Listed drug product patent expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  23. Patent 11154516 expires

    Listed method-of-use patent (U-3235) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  24. Patent 11154516 expires

    Listed method-of-use patent (U-3236) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  25. Patent 11311498 expires

    Listed method-of-use patent (U-3375) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  26. Patent 11311498 expires

    Listed method-of-use patent (U-3376) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  27. Patent 11357741 expires

    Listed method-of-use patent (U-2862) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  28. Patent 11446258 expires

    Listed method-of-use patent (U-2780) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  29. Patent 11446258 expires

    Listed method-of-use patent (U-2781) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  30. Patent 11446258 expires

    Listed method-of-use patent (U-3071) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  31. Patent 11633369 expires

    Listed drug product patent expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  32. Patent 11633369 expires

    Listed drug product patent expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  33. Patent 11633369 expires

    Listed drug product patent expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  34. Patent 11701330 expires

    Listed method-of-use patent (U-2780) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  35. Patent 11701330 expires

    Listed method-of-use patent (U-2781) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  36. Patent 11766411 expires

    Listed method-of-use patent (U-2781) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  37. Patent 11963937 expires

    Listed method-of-use patent (U-2780) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  38. Patent 11963937 expires

    Listed method-of-use patent (U-2781) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  39. Patent 12064399 expires

    Listed method-of-use patent (U-3988) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  40. Patent 12064399 expires

    Listed method-of-use patent (U-3989) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  41. Patent 9949937 expires

    Listed method-of-use patent (U-2421) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  42. Patent 9956183 expires

    Listed method-of-use patent (U-2422) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  43. Patent 9956183 expires

    Listed method-of-use patent (U-2423) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  44. Patent 9956184 expires

    Listed method-of-use patent (U-2424) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  45. Patent 9956185 expires

    Listed method-of-use patent (U-2425) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  46. Patent 9956186 expires

    Listed method-of-use patent (U-2426) expiration.

    Jun 17, 2035

    in 9 yr 2 mo

  47. Patent 10918608 expires

    Listed method-of-use patent (U-3072) expiration.

    Oct 13, 2035

    in 9 yr 5 mo

  48. Patent 10918608 expires

    Listed method-of-use patent (U-3071) expiration.

    Oct 13, 2035

    in 9 yr 5 mo

  49. Patent 10918608 expires

    Listed method-of-use patent (U-3073) expiration.

    Oct 13, 2035

    in 9 yr 5 mo

  50. Patent 11065209 expires

    Listed method-of-use patent (U-3071) expiration.

    Oct 13, 2035

    in 9 yr 5 mo

  51. Patent 11096905 expires

    Listed drug substance patent expiration.

    Oct 13, 2035

    in 9 yr 5 mo

  52. Patent 11096905 expires

    Listed drug substance patent expiration.

    Oct 13, 2035

    in 9 yr 5 mo

  53. Patent 11400055 expires

    Listed method-of-use patent (U-3071) expiration.

    Oct 13, 2035

    in 9 yr 5 mo

  54. Patent 11207292 expires

    Listed drug substance patent expiration.

    Apr 26, 2039

    in 13 yr

  55. Patent 11207292 expires

    Listed drug substance patent expiration.

    Apr 26, 2039

    in 13 yr

  56. Patent 11207292 expires

    Listed drug substance patent expiration.

    Apr 26, 2039

    in 13 yr

  57. Patent 11865102 expires

    Listed drug substance patent expiration.

    Apr 26, 2039

    in 13 yr

  58. Patent 11865102 expires

    Listed drug substance patent expiration.

    Apr 26, 2039

    in 13 yr

  59. Patent 11865102 expires

    Listed drug substance patent expiration.

    Apr 26, 2039

    in 13 yr

  60. Patent 11160795 expires

    Listed method-of-use patent (U-3233) expiration.

    Mar 01, 2041

    in 14 yr 11 mo

  61. Patent 11406623 expires

    Listed method-of-use patent (U-3233) expiration.

    Mar 01, 2041

    in 14 yr 11 mo

  62. Patent 12102619 expires

    Listed method-of-use patent (U-3233) expiration.

    Mar 01, 2041

    in 14 yr 11 mo

Pharmaceutical detail

Active ingredient

CANNABIDIOL

Strength

100MG/ML

Dosage form

SOLUTION

Route

ORAL

TE code

Not listed

Application

NDA 210365

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (3)

  • M-270New use / labeling-change exclusivity (3 years)

    Oct 20, 2026

    in 4 mo

  • ODE-326Orphan-drug exclusivity (7 years)

    Jul 31, 2027

    in 1 yr 2 mo

  • ODE-332Orphan-drug exclusivity (7 years)

    Jul 31, 2027

    in 1 yr 2 mo

Listed patents (57)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10092525Jun 17, 2035in 9 yr 2 mo
U-2427
10111840Jun 17, 2035in 9 yr 2 mo
U-2443
10111840Jun 17, 2035in 9 yr 2 mo
U-2442
10137095Jun 17, 2035in 9 yr 2 mo
U-2454
10137095Jun 17, 2035in 9 yr 2 mo
U-2455
10603288Jun 17, 2035in 9 yr 2 mo
U-2780
10603288Jun 17, 2035in 9 yr 2 mo
U-2781
10603288Jun 17, 2035in 9 yr 2 mo
U-2782
10603288Jun 17, 2035in 9 yr 2 mo
U-2783
10709671Jun 17, 2035in 9 yr 2 mo
U-2862
10709673Jun 17, 2035in 9 yr 2 mo
Product
10709674Jun 17, 2035in 9 yr 2 mo
U-2781
10709674Jun 17, 2035in 9 yr 2 mo
U-2780
10849860Jun 17, 2035in 9 yr 2 mo
U-2427
10849860Jun 17, 2035in 9 yr 2 mo
U-2454
10966939Jun 17, 2035in 9 yr 2 mo
ProductU-2780
10966939Jun 17, 2035in 9 yr 2 mo
ProductU-2781
11154516Jun 17, 2035in 9 yr 2 mo
U-3235
11154516Jun 17, 2035in 9 yr 2 mo
U-3236
11311498Jun 17, 2035in 9 yr 2 mo
U-3375
11311498Jun 17, 2035in 9 yr 2 mo
U-3376
11357741Jun 17, 2035in 9 yr 2 mo
U-2862
11446258Jun 17, 2035in 9 yr 2 mo
U-2780
11446258Jun 17, 2035in 9 yr 2 mo
U-2781
11446258Jun 17, 2035in 9 yr 2 mo
U-3071
11633369Jun 17, 2035in 9 yr 2 mo
ProductU-2780
11633369Jun 17, 2035in 9 yr 2 mo
ProductU-3071
11633369Jun 17, 2035in 9 yr 2 mo
ProductU-2781
11701330Jun 17, 2035in 9 yr 2 mo
U-2780
11701330Jun 17, 2035in 9 yr 2 mo
U-2781
11766411Jun 17, 2035in 9 yr 2 mo
U-2781
11963937Jun 17, 2035in 9 yr 2 mo
U-2780
11963937Jun 17, 2035in 9 yr 2 mo
U-2781
12064399Jun 17, 2035in 9 yr 2 mo
U-3988
12064399Jun 17, 2035in 9 yr 2 mo
U-3989
9949937Jun 17, 2035in 9 yr 2 mo
U-2421
9956183Jun 17, 2035in 9 yr 2 mo
U-2422
9956183Jun 17, 2035in 9 yr 2 mo
U-2423
9956184Jun 17, 2035in 9 yr 2 mo
U-2424
9956185Jun 17, 2035in 9 yr 2 mo
U-2425
9956186Jun 17, 2035in 9 yr 2 mo
U-2426
10918608Oct 13, 2035in 9 yr 5 mo
U-3072
10918608Oct 13, 2035in 9 yr 5 mo
U-3071
10918608Oct 13, 2035in 9 yr 5 mo
U-3073
11065209Oct 13, 2035in 9 yr 5 mo
U-3071
11096905Oct 13, 2035in 9 yr 5 mo
SubstanceProductU-2780
11096905Oct 13, 2035in 9 yr 5 mo
SubstanceProductU-2781
11400055Oct 13, 2035in 9 yr 5 mo
U-3071
11207292Apr 26, 2039in 13 yr
SubstanceU-3235
11207292Apr 26, 2039in 13 yr
SubstanceU-3277
11207292Apr 26, 2039in 13 yr
SubstanceU-3236
11865102Apr 26, 2039in 13 yr
SubstanceProductU-2781
11865102Apr 26, 2039in 13 yr
SubstanceProductU-3236
11865102Apr 26, 2039in 13 yr
SubstanceProductU-3277
11160795Mar 01, 2041in 14 yr 11 mo
U-3233
11406623Mar 01, 2041in 14 yr 11 mo
U-3233
12102619Mar 01, 2041in 14 yr 11 mo
U-3233
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.